Advertisement · 728 × 90
#
Hashtag
#tnkase
Advertisement · 728 × 90
Preview
What Doctors Need to Know About Tenecteplase’s New FDA Approval for Stroke In a significant advancement for acute ischemic stroke (AIS) treatment, the U.S. Food and Drug Administration (FDA) has approved…

Tenecteplase (TNKase) is officially approved for stroke treatment — faster, simpler, and shaking up thrombolysis protocols.

Here’s what every physician needs to know 👇
medium.com/@henalodhia/...

#StrokeCare #FDA #Medicine #Neurology #TNKase

0 0 0 0
Preview
Clot-Busting Drug, TNKase, Quicker And As Effective In Treating Stroke - Drugs.com MedNews A newly approved clot- busting drug for stroke works as well as a decades-old medication still used by most U.S. hospitals, and can be delivered even more quick

New stroke medication #TNKase gets FDA approval, works as well as standard treatment but can be delivered faster. Research published in JAMA Network Open confirms the first new clot-busting drug in 30 years performs equally to alteplase, which has been the standard care.

0 0 0 0
Preview
FDA Approves New Treatments: A Summary of Key Developments for March 2025 The FDA's latest approvals include the first generic of Xarelto and a new treatment for acute ischemic stroke, indicating a busy month for the agency.

FDA Approves New Treatments: A Summary of Key Developments for March 2025 #USA #FDA #Silver_Spring #Xarelto #TNKase

0 0 0 0
Preview
Critical Care Management of Acute Venous Thromboembolism: Integrating Pharmacotherapy, Thrombectomy, and Temporary Mechanical Support Venous thromboembolism (VTE), which includes pulmonary embolism and deep vein thrombosis, carries significant morbidity and mortality risks, and is conventionally managed with

'Critical Care Management of Acute Venous Thromboembolism: Integrating Pharmacotherapy, Thrombectomy, and Temporary Mechanical Support'
#tnkase #thrombectomy #FlowTriever #ecmo #PE #vte #dvt pulmonary embolism #pulmSky #emimcc
www.uscjournal.com/articles/cri...

10 2 0 1

' #Tenecteplase versus #alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial'
#tnkase #tpa #stroke #cva #medsky #neurosky
www.thelancet.com/action/showP...

1 1 0 0